Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil vs Tamsulosin vs Combination in BPH
NCT05236634Unknown
- Sponsor
- Assiut University
- Start
- May 2022
- Primary completion
- May 2024
- Modality
- Small Molecules
01
Overview
Randomised trial of tadalafil in benign prostatic hyperplasia (BPH) (3 arms), sponsored by Assiut University. Primary endpoints: International Prostate Symptom Score at 12 weeks, International Index of Erectile Function at 12 weeks and 1 more. Status: unknown.
02
Drugs
tadalafil
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT05236634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05236634.